Face-scanning A.I. Can Help Doctors Spot Unusual Genetic Disorders

January 14, 2019

Digital Trends 

“DeepGestalt is a facial image analysis framework that can highlight similarities to hundreds of genetic disorders. It is a type of artificial intelligence that can efficiently learn the relevant visual appearances of genetic conditions, and provide relevancy scores for them. It is based on the recent machine learning tools, called deep learning. In practice, we use artificial neural networks to learn subtle patterns in the face and create a mathematical representation for those. DeepGestalt is like a mathematical aggregated representation of the knowledge of thousands of experts.”

 

The article from Digital Trends discusses how FDNA’s Face2Gene technology leverages AI to assist doctors in diagnosing unusual genetic disorders using facial scans. Face2Gene analyzes photographs of patients’ faces to identify subtle phenotypic features linked to specific genetic conditions. This innovative decision support tool empowers medical professionals to achieve quicker and more accurate diagnoses, particularly for rare and complex genetic disorders that are difficult to identify through traditional methods. The technology marks a significant advancement in personalized medicine, improving patient care by enabling early intervention.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading